The latest Investing Matters Podcast episode featuring financial educator and author Jared Dillian has been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksShire Share News (SHP)

  • There is currently no data for SHP

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Asian Shares Mixed Despite US-China Trade Deal Optimism

Tue, 08th Jan 2019 08:58

CANBERA (Alliance News) - Asian stocks ended mixed on Tuesday despite optimism over US-China trade talks as US officials held a second day of trade talks with Chinese counterparts in Beijing.

The second day of negotiations coincided with an unannounced visit by North Korean leader Kim Jong Un, with some analysts saying China could use Kim's visit as a bargaining chip in the US trade talks.

China's Shanghai Composite index slid 0.26% to 2,526.46 while Hong Kong's Hang Seng index rose 0.15% to 25,875.45.

Japanese shares ended on a positive note after Amazon and Microsoft Corp fueled a second straight session of gains on Wall Street overnight.

The Nikkei average gained 165.07 points or 0.82% to finish at 20,204.04 while the broader Topix index closed 0.39% higher at 1,518.43.

Automaker Honda Motor rallied 3.2% and Toyota rose 1.2% while banks Mitsubishi UFJ Financial, Sumitomo Mitsui Financial and Mizuho Financial rose between 0.3% and 1.3%.

Takeda Pharmaceutical climbed 2.3% after completing its acquisition of Irish drugmaker Shire. Inpex and Japan Petroleum gained around 1% after crude oil prices rose more than 1% overnight.

Olympus Corp jumped 8.4% after Morgan Stanley upgraded the stock's rating to "overweight" from "equal-weight".

Seoul stocks fell as investors monitored the second day of trade talks between China and the US. The benchmark Kospi dropped 11.83 points or 0.58% to 2,025.27. Samsung Electronics lost 1.7% after it partnered with tech giant Apple Inc. to bring iTunes content to Samsung smart televisions.

On the data front, South Korea posted a current account surplus of USD5.06 billion in November, the Bank of Korea said - down from the USD9.19 billion surplus in October. The goods account surplus stood at USD7.97 billion, down from USD11.46 billion in November 2017.

Australian markets closed notably higher amid signs that Beijing and Washington may be inching closer toward a trade deal.

Traders shrugged off weak trade data showing that the country had a seasonally adjusted merchandise trade surplus of AUD1.925 billion in November, shy of expectations for a surplus of AUD2.175 billion and down from AUD2.316 billion in October.

The benchmark S&P/ASX 200 index rose 39.20 points or 0.69% to 5,722.40 while the broader All Ordinaries index ended higher by 38.80 points or 0.68% at 5,783.30.

Banks ANZ, NAB and Westpac rose between 0.9% and 1.2%. Waste management giant Bingo Industries soared 5.7% after it offered to sell its Sydney processing plant to address antitrust concerns related to the planned acquisition of Dial-aDump.

Gold miner Evolution lost 3.4%, St Barbara tumbled 5% and Northern Star Resources declined 2.6% as dovish comments from the Fed boosted investors' appetite for risk.

Sleep device maker ResMed advanced 1.4% after completing the USD225 million acquisition of US-based asthma and pulmonary specialist Propeller Health.

New Zealand shares rose modestly, with the benchmark S&P/NZX 50 index finishing up 15.11 points or 0.17% at 8,821.15.

U.S stocks rose overnight as the US and China resumed talks on their trade war and Federal Reserve Chair Jerome Powell said the central bank would be "flexible" in its approach to monetary policy.

The Dow Jones Industrial Average rose 0.4%, the tech-heavy Nasdaq Composite rallied 1.3% and the S&P 500 climbed 0.7%.

More News
19 Apr 2018 15:32

BUZZ-Shire: Allergan mulls bid for co

(Updates with Allergan news) ** Shire +8.7 pct, top of FTSE 100 in volume ** Co rejects a third takeover bid worth nearly $63 bln from Japan's Takeda Pharmaceutical, although is

Read more
19 Apr 2018 15:05

EXCLUSIVE-Allergan in talks to acquire Shire, competing against Takeda-sources

April 19 (Reuters) - Botox maker Allergan Plc is in talks to acquire Shire Plc, competing against Japan's Takeda Pharmaceutical Co Ltd for the London-listed drugmaker, two sources familiar the

Read more
19 Apr 2018 14:38

UPDATE: Shire Rejects 3 Takeda Proposals But Initiates Talks (ALLISS)

LONDON (Alliance News) - Irish pharmaceutical firm Shire PLC on Thursday said it has received three takeover proposals from Takeda Pharmaceutical Co Ltd since the end of March, all of which it has

Read more
19 Apr 2018 13:58

UPDATE 1-Takeda in talks with Shire after $61 bln bid rejected

By Ben Martin, Greg Roumeliotis and Ben Hirschler LONDON/NEW YORK, April 19 (Reuters) - Japan's Takeda Pharmaceutical is in negotiations with Shire after making a third takeover bid $61

Read more
19 Apr 2018 13:33

Reuters Business News Schedule at 1230 GMT/830AM ET

Editor: Keith Weir, +44 20 7542 8022 Global Picture Desk: +65 6870 3775 Global Graphics Desk: + 65 6870 3595 (All times GMT / ET) Receive this schedule by Unilever over

Read more
19 Apr 2018 13:26

TOP NEWS: Takeda Confirms Shire Rejected GBP42 Billion Takeover Bid

LONDON (Alliance News) - Takeda Pharmaceutical Co Ltd on Thursday confirmed it made a revised takeover proposal to Shire PLC a week ago, which the Irish pharmaceutical firm rejected.The was

Read more
19 Apr 2018 13:23

Takeda in talks with Shire after 46.50 stg/shr bid rejected

LONDON, April 19 (Reuters) - Japan's Takeda Pharmaceutical said on Thursday it was in negotiations with Shire after making a bid worth 46.50 pounds per share that was rejected by the rare that

Read more
19 Apr 2018 13:07

RPT-UPDATE 2-Takeda makes $61 bln bid for drugmaker Shire -sources

By Greg Roumeliotis and Ben Martin LONDON, April 19 (Reuters) - Takeda Pharmaceutical has made a bid for Shire that values the London-listed drugmaker at around $61 billion, two sources of

Read more
19 Apr 2018 12:38

BUZZ-Shire: Takeda makes $61 bln bid for drugmaker -sources

** Shire +7.2 pct and top of FTSE 100 in heavy volume ** Japan's Takeda Pharmaceutical has made a bid for Shire that values co at c$61 bln, two sources with direct knowledge of the tell

Read more
19 Apr 2018 12:21

PRESS: Takeda Pharma Makes Takeover Proposal For Shire - Reuters

LONDON (Alliance News) - Japanese pharmaceutical group Takeda Pharmaceutical Co Ltd made a takeover offer for Irish drugmaker Shire PLC, Reuters published on Thursday.Reuters reported has a

Read more
19 Apr 2018 11:47

UPDATE 1-Takeda makes Shire takeover proposal at about 46.50 stg/shr -sources

By Greg Roumeliotis and Ben Martin LONDON, April 19 (Reuters) - Takeda Pharmaceutical has made an indicative takeover proposal to British drugmaker Shire worth about 46.50 pounds a share, a

Read more
19 Apr 2018 11:22

Takeda makes Shire takeover proposal at about 46.50 stg/shr -sources

LONDON, April 19 (Reuters) - Takeda Pharmaceutical has made an indicative takeover proposal to British drugmaker Shire worth about 46.50 pounds a share, according to two sources, one of which has

Read more
18 Apr 2018 10:03

Shire faces criticism on CEO pay policy as crunch week looms

* Japan's Takeda to decide on takeover bid by April 25 * Shire holds AGM on April 24, reports Q1 results April 26 * CEO came under fire for 2016 Baxalta deal By Ben April

Read more
17 Apr 2018 16:07

UK Shareholder Meetings Calendar - Next 7 Days

Wednesday 18 AprilBunzlRTC Group88 EnergyEuropean Assets Wealth Group (re issuance of

Read more
4 Apr 2018 17:15

UPDATE 1-Defensive FTSE 100 ekes out a gain amid global trade sell-off

* FTSE 100 up 0.1 pct * Trade tensions weigh on stocks * WPP drops after co to probe CEO (Updates prices, adds details) By Kit Rees and Helen April 4 (Reuters) - FTSE 100 gain

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.